$1.32
-0.19-12.58%
가까이에: Nov 18, 4:00 PM EST
$1.49
0.1712.88%
시간외: 8:58 AM EST

The average analyst price target for PAVmed is $57, 3725.5% above the current price. The one analyst covering it rates it Buy. The latest change came on Aug 27, 2026, when Ascendiant Capital raised its price target on PAVmed from $56 to $57 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months